NCT01803087View on ClinicalTrials.gov

Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Asthma
Interventions
DRUG

Test treatments CHF 1535 100/6 pMDI (Foster®) TEST1

DRUG

CHF 1535 100/6 pMDI (Foster®) using AeroChamber Plus™ (TEST 2).

DRUG

BDP pMDI 100 µg (Qvar®) plus formoterol fumarate pMDI 6 µg (Atimos®) (REF)

DRUG

CHF 1535 100/6 pMDI (Foster®) (CTR)

Trial Locations (1)

90153

Uniwersytecki Szpital Kliniczny nr 1, Lodz

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01803087 - Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients | Biotech Hunter | Biotech Hunter